Spironolactone

Spironolactone, sold as Aldactone, is an aldosterone antagonist, a medicine taken by mouth that blocks the hormone aldosterone. The US label read, for Aldactone tablets, lists four uses: heart failure with reduced ejection fraction in people with the more severe symptom classes (NYHA class III to IV), to increase survival, manage swelling and reduce hospital stays for heart failure; add-on treatment of high blood pressure; swelling in adults with cirrhosis of the liver or in the nephrotic syndrome when the measures the label names first have not worked well enough; and primary hyperaldosteronism.

Also called Aldactone

  • Drug
  • In this atlas

Overview

Technical summary

RxNorm ingredient 9997; UNII 27O7W4T232. MeSH descriptor D013148 is Spironolactone. Class: Aldosterone Antagonist (FDA established pharmacologic class, RxClass). The label read is the Pfizer Laboratories Div Pfizer Inc label for Aldactone tablets, application NDA012151, effective 2025-11-28 in openFDA. The plan row pointed at a spironolactone and hydrochlorothiazide combination label; the single-ingredient brand label replaces it. The combination product (Aldactazide, NDA012616) and generic labels were not read. This page records label indications, the mechanism sentence and the class only: no trial result and no dose is given.

About this drug

Level
Substance
Mechanism
The label says spironolactone and its active metabolites are specific pharmacologic antagonists of aldosterone.

Claims and evidence

Context Patients with NYHA class III to IV heart failure (reduced ejection fraction), hypertension, edema or primary hyperaldosteronism, as described in the US label of Aldactone tablets

Recipient
Recipient not specified
Population
Patients described in the indications section of the label: people with NYHA class III to IV heart failure and reduced ejection fraction, people with hypertension, adults with edema from cirrhosis of the liver or the nephrotic syndrome, and people with primary hyperaldosteronism. The passages read do not state an age range for each use.
Care setting
Prescription medicine, as described in the US label
Geography
United States (label of the US Food and Drug Administration)
Life stage
Not stated for each use in the label passages read
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (label statement)
Eligibility: 4 inclusion criteria; exclusion criteria not stated
Included
  • Patients with NYHA Class III to IV heart failure and reduced ejection fraction
  • Patients with hypertension who are not adequately controlled on other agents
  • Patients with edema in cirrhosis of the liver or the nephrotic syndrome
  • Patients with primary hyperaldosteronism
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The US label of Aldactone (spironolactone tablets, Pfizer Laboratories Div Pfizer Inc, application NDA012151; the version dated 2025-11-28 in openFDA) describes spironolactone as an aldosterone antagonist. It lists the treatment of NYHA class III to IV heart failure with reduced ejection fraction to increase survival, manage edema and reduce the need for hospitalization for heart failure; add-on treatment of hypertension; the management of edema in cirrhosis of the liver and in the nephrotic syndrome in the settings the label names; and treatment of primary hyperaldosteronism, as short-term preoperative treatment and as long-term maintenance therapy in the settings the label names.

    Applies to Recipient not specified Patients with NYHA class III to IV heart failure (reduced ejection fraction), hypertension, edema or primary hyperaldosteronism, as described in the US label of Aldactone tablets

    Certainty method
    Not assessed
    Limitations
    This claim records what one US label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label says the heart failure use is usually together with other heart failure therapies; that is not an atlas recommendation. Contraindications, warnings (including raised potassium), interactions and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
    Last checked
    2026-11-18
    Next evidence check due
    Not scheduled
    Sources and citations (6)
    1. Supports openFDA drug label record for Aldactone (spironolactone tablets), Pfizer Laboratories Div Pfizer Inc label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 0fed2822-3a03-4b64-9857-c682fcd462bc (manufacturer Pfizer Laboratories Div Pfizer Inc, application NDA012151), returned on 2026-11-18. The label text is dated 2025-11-28 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE
      How it applies
      Label passage quoted in the research quote table (LB-04).
      Retrieved
      Source effective date
      2025-11-28
      Source state
      Current
      Version fingerprint
      7a66be80d86367d4142306a143a4c600b7a1fd0b1e32977782824e8cd08cdc91
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    2. Supports openFDA drug label record for Aldactone (spironolactone tablets), Pfizer Laboratories Div Pfizer Inc label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 0fed2822-3a03-4b64-9857-c682fcd462bc (manufacturer Pfizer Laboratories Div Pfizer Inc, application NDA012151), returned on 2026-11-18. The label text is dated 2025-11-28 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1.1 Heart Failure
      How it applies
      Label passage quoted in the research quote table (LB-05, LB-10).
      Retrieved
      Source effective date
      2025-11-28
      Source state
      Current
      Version fingerprint
      7a66be80d86367d4142306a143a4c600b7a1fd0b1e32977782824e8cd08cdc91
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    3. Supports openFDA drug label record for Aldactone (spironolactone tablets), Pfizer Laboratories Div Pfizer Inc label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 0fed2822-3a03-4b64-9857-c682fcd462bc (manufacturer Pfizer Laboratories Div Pfizer Inc, application NDA012151), returned on 2026-11-18. The label text is dated 2025-11-28 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1.2 Hypertension
      How it applies
      Label passage quoted in the research quote table (LB-06).
      Retrieved
      Source effective date
      2025-11-28
      Source state
      Current
      Version fingerprint
      7a66be80d86367d4142306a143a4c600b7a1fd0b1e32977782824e8cd08cdc91
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    4. Supports openFDA drug label record for Aldactone (spironolactone tablets), Pfizer Laboratories Div Pfizer Inc label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 0fed2822-3a03-4b64-9857-c682fcd462bc (manufacturer Pfizer Laboratories Div Pfizer Inc, application NDA012151), returned on 2026-11-18. The label text is dated 2025-11-28 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1.3 Edema Associated with Hepatic Cirrhosis or Nephrotic Syndrome
      How it applies
      Label passage quoted in the research quote table (LB-07, LB-11).
      Retrieved
      Source effective date
      2025-11-28
      Source state
      Current
      Version fingerprint
      7a66be80d86367d4142306a143a4c600b7a1fd0b1e32977782824e8cd08cdc91
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    5. Supports openFDA drug label record for Aldactone (spironolactone tablets), Pfizer Laboratories Div Pfizer Inc label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 0fed2822-3a03-4b64-9857-c682fcd462bc (manufacturer Pfizer Laboratories Div Pfizer Inc, application NDA012151), returned on 2026-11-18. The label text is dated 2025-11-28 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1.4 Primary Hyperaldosteronism
      How it applies
      Label passage quoted in the research quote table (LB-08, LB-12).
      Retrieved
      Source effective date
      2025-11-28
      Source state
      Current
      Version fingerprint
      7a66be80d86367d4142306a143a4c600b7a1fd0b1e32977782824e8cd08cdc91
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    6. Background openFDA drug label record for Aldactone (spironolactone tablets), Pfizer Laboratories Div Pfizer Inc label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 0fed2822-3a03-4b64-9857-c682fcd462bc (manufacturer Pfizer Laboratories Div Pfizer Inc, application NDA012151), returned on 2026-11-18. The label text is dated 2025-11-28 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].effective_time
      How it applies
      Effective date of the label text read, 20251128.
      Retrieved
      Source effective date
      2025-11-28
      Source state
      Current
      Version fingerprint
      7a66be80d86367d4142306a143a4c600b7a1fd0b1e32977782824e8cd08cdc91
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Record details

Record id
cardio:spironolactone
Content hash
623116861745a51c1146b1091d7a921d11dfd2f1ae34d642fa946fff70c173a3